IGF2 and hepatocellular carcinoma: In hepatocellular carcinoma (HCC), the expression of miR-483-3p is related to the mutational status of TP53, CTNNB1 genes and impaired epigenetic mechanisms affecting the IGF2/miR-483/H19 locus.